Thyroid disorders in women: what the statistics tell us about diagnosis and missed cases

A few years ago, a 36-year-old patient came in complaining of fatigue, weight gain, and thinning hair. She had seen two other doctors. One told her to exercise more. The other suggested she might be depressed. Neither had checked her thyroid. A simple blood test (TSH and free T4) revealed severe hypothyroidism with a TSH of 47 mIU/L, more than ten times the upper limit of normal. She had been walking around with a thyroid that had essentially stopped working, and nobody had thought to look.

Thyroid disorders are among the most common endocrine conditions in the world. They disproportionately affect women. And a disturbing number of cases are undiagnosed, with symptoms attributed to stress, aging, or depression instead. The data on this gap between disease prevalence and detection rates is worth looking at carefully.

How common is thyroid disease in women

The American Thyroid Association estimates that more than 20 million Americans have some form of thyroid disease. About 12% of the U.S. population will develop a thyroid condition during their lifetime. But those overall numbers mask a dramatic sex difference: when you look at women alone, the lifetime risk is approximately 1 in 8.

Hypothyroidism is the more common form. A 2014 European meta-analysis by Garmendia Madariaga and colleagues, published in the Journal of Clinical Endocrinology & Metabolism, analyzed 19 studies covering over 100,000 participants and found an overall prevalence of undiagnosed hypothyroidism of 4.94%, with significantly higher rates in women and older adults. Clinical hypothyroidism (overt, symptomatic) affects about 2% to 5% of women, while subclinical hypothyroidism (mildly elevated TSH with normal thyroid hormone levels) affects an additional 5% to 10%.

Hyperthyroidism is less common, affecting roughly 1% to 2% of women. Graves' disease, an autoimmune condition where antibodies overstimulate the thyroid, accounts for about 60% to 80% of hyperthyroidism cases. It is seven to eight times more common in women than men.

The Hollowell study, based on NHANES III data from 1988 to 1994, remains one of the most thorough population-level assessments of thyroid function in the United States. It found that 4.6% of the U.S. population (aged 12 and older) had hypothyroidism: 0.3% clinical and 4.3% subclinical. Women had significantly higher rates across all measures of thyroid dysfunction.

The gender gap and why it exists

The 5-to-8-times higher risk in women is not a small difference. It is one of the largest sex-based disease disparities in medicine, and the reasons are primarily immunological.

Autoimmune diseases as a group are far more common in women. About 80% of all autoimmune disease occurs in women, and thyroid autoimmunity follows the same pattern. Hashimoto's thyroiditis and Graves' disease are both autoimmune conditions, and they account for the vast majority of thyroid dysfunction.

The leading explanations center on sex hormones and X-chromosome genetics. Estrogen modulates immune function in ways that can promote autoimmunity — it enhances B-cell survival and antibody production, which is protective against infections but increases the risk of self-directed immune attacks. The X chromosome carries a disproportionate number of immune-related genes, and women have two copies. While one is typically inactivated, incomplete inactivation (which occurs in a subset of cells) may expose the immune system to antigens it would not otherwise see.

Pregnancy is a particularly high-risk period for thyroid autoimmunity. The immune shifts that occur during and after pregnancy (tolerance during gestation, rebound immune activation postpartum) can trigger new-onset thyroid disease. Postpartum thyroiditis affects 5% to 10% of women in the first year after delivery.

Hashimoto's disease: the most common cause

Hashimoto's thyroiditis is the most common cause of hypothyroidism in the United States and in all countries with adequate iodine intake. The National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) describes it as a condition in which the immune system attacks the thyroid gland, gradually destroying its ability to produce hormones.

The NHANES III data found that 11.3% of U.S. women had detectable thyroid peroxidase (TPO) antibodies — a marker of autoimmune thyroid inflammation. Not all of these women had clinical hypothyroidism at the time of testing, but the presence of TPO antibodies is a strong predictor of developing hypothyroidism over the following years. Roughly 2% to 4% of women with positive TPO antibodies progress to overt hypothyroidism each year.

What Hashimoto's looks like clinically varies enormously. Some women have a slow, progressive decline in thyroid function that unfolds over a decade. Others experience fluctuations — periods of hypothyroidism alternating with normal function or even transient hyperthyroidism as damaged thyroid cells release stored hormone. The classic symptoms include fatigue, cold intolerance, weight gain, dry skin, constipation, hair loss, and brain fog. But none of those symptoms is specific to thyroid disease, which is exactly the problem.

A goiter (enlarged thyroid) is present in some but not all cases. In its later stages, Hashimoto's can actually cause the thyroid to shrink as the gland is replaced by scar tissue.

The 60 percent who don't know

The ATA estimates that up to 60% of people with thyroid disease are unaware of their condition. That is a staggering number for a disease that is easily diagnosed with a blood test and, in most cases, effectively treated.

Why do so many cases go undetected? The answer is frustratingly simple: the symptoms look like other things.

Fatigue is the most common symptom of hypothyroidism. It is also the most common complaint in primary care in general. Weight gain, mood changes, and difficulty concentrating accompany hypothyroidism, but they also accompany stress, sleep deprivation, perimenopause, and depression. Without a blood test, there is no way to distinguish thyroid-caused fatigue from any other kind.

The data supports that clinical impression. The mean time from symptom onset to diagnosis for hypothyroidism ranges from 4 to 5 years in some studies.

Subclinical hypothyroidism complicates things further. In this state, TSH is mildly elevated (typically 4.5 to 10 mIU/L) but free T4 is still normal. Many patients have symptoms. Some do not. The debate over whether to treat subclinical disease has persisted for years, and guidelines vary: the ATA recommends treatment when TSH exceeds 10, but many clinicians treat at lower levels if the patient is symptomatic, has TPO antibodies, or is trying to become pregnant.

If you are experiencing persistent fatigue, unexplained weight changes, or cycle irregularities, our perimenopause symptom guide covers the overlap between perimenopause and thyroid disease — they share many symptoms and can coexist. A TSH test is a reasonable request at any routine appointment.

Thyroid disease and fertility

Thyroid hormones regulate nearly every organ system in the body, and the reproductive system is particularly sensitive to their levels. Both hypothyroidism and hyperthyroidism can disrupt the menstrual cycle, impair ovulation, and reduce the likelihood of conception.

In hypothyroidism, elevated TSH can suppress the pulsatile release of gonadotropin-releasing hormone (GnRH), leading to irregular or absent ovulation. Elevated prolactin levels, which sometimes accompany hypothyroidism, can further disrupt the ovulatory cycle. Women with untreated hypothyroidism may experience heavy or prolonged periods, or conversely, very light or infrequent periods.

Hyperthyroidism can also disrupt menstrual cycles, though the pattern tends toward lighter, less frequent periods due to the effects of excess thyroid hormone on sex-hormone-binding globulin and estrogen metabolism.

The American Society for Reproductive Medicine (ASRM) recommends thyroid screening for all women presenting with infertility. The ATA recommends checking TSH before pregnancy in women with known thyroid disease, a personal or family history of autoimmune conditions, or a history of recurrent miscarriage. Despite these recommendations, thyroid testing is not universally performed during infertility workups, and some women go through multiple failed cycles before someone thinks to check it.

Subclinical hypothyroidism is particularly relevant for fertility. A TSH level above 2.5 mIU/L (well within the "normal" range for the general population) has been associated with longer time to conception and higher miscarriage risk in some studies, though not all. The ATA's pregnancy guidelines recommend a TSH target of less than 2.5 mIU/L for women trying to conceive, and some fertility clinics treat preemptively with low-dose levothyroxine when TSH is between 2.5 and 4.5 in the presence of TPO antibodies.

If you are trying to conceive and tracking ovulation, our ovulation calculator can help identify your fertile window, but if your cycles are irregular, that may be a signal to check your thyroid function first.

Thyroid disorders during pregnancy

The thyroid works harder during pregnancy. Demand for thyroid hormone increases by roughly 30% to 50% in the first trimester, driven by rising hCG levels (which stimulate the thyroid) and expanding blood volume. A thyroid that is already borderline or compromised may not be able to meet that demand.

The ATA's 2017 pregnancy guidelines, authored by Alexander and colleagues and published in Thyroid, represent the most thorough evidence-based framework for managing thyroid disease in pregnancy. Key recommendations include:

• Women with known hypothyroidism should increase their levothyroxine dose by approximately 20% to 30% as soon as pregnancy is confirmed
• TSH should be maintained below 4.0 mIU/L during pregnancy, with many clinicians targeting below 2.5 in the first trimester
• Universal screening for thyroid disease in pregnancy is not currently recommended by the ATA, though targeted screening of high-risk women is

Untreated overt hypothyroidism during pregnancy carries serious risks: miscarriage (odds ratio approximately 2 to 4 times higher than in euthyroid women), preterm delivery, preeclampsia, and impaired neurocognitive development in the child. A landmark study by Haddow and colleagues in the New England Journal of Medicine (1999) found that children born to women with untreated hypothyroidism during pregnancy scored an average of 7 points lower on IQ tests at age 7 to 9.

Postpartum thyroiditis (which typically presents as transient hyperthyroidism followed by hypothyroidism in the first year after delivery) affects 5% to 10% of women. About 25% to 30% of women who develop postpartum thyroiditis will go on to have permanent hypothyroidism within 5 to 10 years.

For women tracking their pregnancies, our implantation bleeding guide covers early pregnancy signs that may overlap with the fatigue and mood changes associated with thyroid fluctuations.

Thyroid cancer: a separate but related story

Thyroid cancer is three times more common in women than men. The American Cancer Society estimates approximately 44,020 new cases in the U.S. in 2025, with about 33,990 (77%) occurring in women.

The good news is that thyroid cancer has one of the highest survival rates of any cancer. The overall 5-year relative survival rate is approximately 98%. For papillary thyroid cancer, the most common type (accounting for about 80% of cases), the survival rate is even higher.

Thyroid cancer incidence has tripled since the mid-1990s, but most of that increase reflects overdiagnosis — the detection of small papillary tumors through imaging studies performed for other reasons. Mortality has remained essentially flat, which means we are finding more cancers but not saving more lives. This has led to a reassessment of how aggressively small thyroid nodules should be biopsied and treated.

The connection to autoimmune thyroid disease is worth noting. Some studies suggest that Hashimoto's thyroiditis may be associated with a modestly increased risk of thyroid lymphoma and possibly papillary carcinoma, though the absolute risk remains low.

Screening debates and clinical reality

Despite the high prevalence of thyroid disease and the simplicity of testing, universal screening is not recommended by most major guidelines. The U.S. Preventive Services Task Force concluded in 2015 (and reaffirmed) that there is insufficient evidence to recommend for or against routine screening for thyroid dysfunction in nonpregnant, asymptomatic adults.

The ATA takes a more nuanced position, recommending that adults (particularly women) be screened for thyroid disease starting at age 35 and every 5 years thereafter, especially in the presence of risk factors. The American Association of Clinical Endocrinologists (AACE) similarly recommends screening for women of childbearing age.

In practice, whether your thyroid gets tested often depends on whether your doctor thinks to order it. Women who present with fatigue, weight changes, menstrual irregularities, or fertility problems should have TSH checked as a basic part of the workup. It is a $20 to $40 blood test. The cost of not checking it (years of misattributed symptoms, impaired fertility, or pregnancy complications) is far higher.

Specific situations where thyroid testing is clearly indicated:

• Before or early in pregnancy
• During evaluation for infertility or recurrent miscarriage
• New-onset depression or anxiety with fatigue
• Unexplained weight changes (gain or loss)
• Menstrual irregularity not explained by other causes
• Family history of autoimmune thyroid disease
• Personal history of any autoimmune condition (type 1 diabetes, celiac disease, rheumatoid arthritis)
• After head and neck radiation exposure

If your cycles have become irregular, our cycle length calculator can help you quantify what has changed. That information is useful for your doctor when deciding whether to order thyroid labs.

Frequently asked questions about thyroid disorders in women

How common is thyroid disease in women?

Approximately 1 in 8 women will develop a thyroid disorder during her lifetime, according to the American Thyroid Association. Women are 5 to 8 times more likely than men to have thyroid disease. The most common form is hypothyroidism, affecting about 2% to 5% of women clinically, with an additional 5% to 10% having subclinical disease.

What is Hashimoto's thyroiditis?

Hashimoto's is an autoimmune condition where the immune system attacks the thyroid gland, gradually destroying its ability to produce hormones. It is the most common cause of hypothyroidism in the United States and other iodine-sufficient countries. NHANES III data found thyroid peroxidase antibodies (a marker of Hashimoto's) in 11.3% of U.S. women, indicating widespread subclinical autoimmune thyroid activity.

Can thyroid problems cause infertility?

Yes. Both hypothyroidism and hyperthyroidism can disrupt ovulation and menstrual regularity. The American Society for Reproductive Medicine recommends thyroid screening for all women presenting with infertility. Even subclinical hypothyroidism (TSH above 2.5 mIU/L) has been associated with longer time to conception in some studies. The ATA recommends a TSH target below 2.5 for women trying to conceive.

Should I get my thyroid checked during pregnancy?

The ATA's 2017 pregnancy guidelines recommend targeted screening for high-risk women, including those with a personal or family history of thyroid disease, autoimmune conditions, recurrent miscarriage, or prior head/neck radiation. Thyroid demand increases 30% to 50% during pregnancy, and untreated hypothyroidism is associated with miscarriage, preterm birth, and impaired fetal neurodevelopment.

Why do so many people with thyroid disease not know they have it?

The ATA estimates that up to 60% of people with thyroid disease are unaware of their condition. This is because common thyroid symptoms (fatigue, weight changes, mood shifts, brain fog) overlap with stress, sleep deprivation, depression, and perimenopause. Without a blood test (TSH and free T4), there is no reliable way to distinguish thyroid disease from these other conditions. Routine screening is not universally recommended, so many cases go undetected.

Is thyroid cancer common in women?

Thyroid cancer is three times more common in women than men. The American Cancer Society estimates about 33,990 new cases in U.S. women in 2025. However, thyroid cancer has a 98% five-year survival rate overall, and the most common type (papillary thyroid cancer) has an even higher survival rate. Much of the increase in thyroid cancer incidence since the 1990s reflects improved detection of small tumors rather than a true rise in disease.